Edition:
United Kingdom

Mediclinic International PLC (MDCM.L)

MDCM.L on London Stock Exchange

318.50GBp
19 Mar 2019
Change (% chg)

2.60 (+0.82%)
Prev Close
315.90
Open
315.50
Day's High
322.70
Day's Low
309.20
Volume
951,124
Avg. Vol
1,765,618
52-wk High
712.40
52-wk Low
293.10

Latest Key Developments (Source: Significant Developments)

S.Africa's Competition Tribunal Stops Mediclinic Southern Africa- Matlosana Deal
Wednesday, 30 Jan 2019 

Jan 30 (Reuters) - S.AFRICA'S COMPETITION TRIBUNAL::PROHIBITED MERGER BETWEEN MEDICLINIC SOUTHERN AFRICA & MATLOSANA MEDICAL HEALTH SERVICES IN NORTH WEST PROVINCE.  Full Article

Mpilo Investment Holdings 2 (Rf) (Pty) Ltd Dissolves Stake In Mediclinic International Plc - Filing
Tuesday, 29 Jan 2019 

Jan 29 (Reuters) - Mediclinic International PLC ::MPILO INVESTMENT HOLDINGS 2 (RF) (PTY) LTD DISSOLVES STAKE IN MEDICLINIC INTERNATIONAL PLC - FILING.  Full Article

Mediclinic Says Forecast For Middle East Division Unchanged
Wednesday, 12 Dec 2018 

Dec 12 (Reuters) - Mediclinic International PLC ::GUIDANCE FOR MEDICLINIC MIDDLE EAST REMAINS UNCHANGED.MEDICLINIC MIDDLE EAST EXPECTS TO DELIVER FY19 REVENUE GROWTH IN HIGH SINGLE-DIGIT PERCENTAGE RANGE.  Full Article

Mediclinic Experiences Customary Seasonality In Switzerland, Middle East In H1 Trading
Wednesday, 17 Oct 2018 

Oct 17 (Reuters) - Mediclinic International PLC ::MEDICLINIC INTERNATIONAL - IN MIDDLE EAST, 182-BED MEDICLINIC PARKVIEW HOSPITAL IN DUBAI OPENED IN SEPTEMBER ON TIME AND IN BUDGET.MEDICLINIC INTERNATIONAL PLC - RECENTLY COMPLETED BUILD OF OUR FOURTH DAY CLINIC AT MEDICLINIC NEWCASTLE WHICH IS EXPECTED TO OPEN SHORTLY.MEDICLINIC INTERNATIONAL PLC - CONTINUE TO PROGRESS WITH HIRSLANDEN 2020 STRATEGIC PROGRAMME.MEDICLINIC INTERNATIONAL PLC - TRADING IN FIRST HALF OF YEAR EXPERIENCED CUSTOMARY SEASONALITY IN SWITZERLAND AND MIDDLE EAST.MEDICLINIC INTERNATIONAL PLC - IN MIDDLE EAST, WE DELIVERED A GRADUAL IMPROVEMENT IN REVENUE AND MARGIN EXPANSION IN H1.MEDICLINIC INTERNATIONAL PLC - IN SWITZERLAND, BUSINESS CONTINUES TO ADAPT TO RECENT REGULATORY CHANGES IN OUTPATIENT ENVIRONMENT IN H1.MEDICLINIC INTERNATIONAL PLC - IN SOUTHERN AFRICA, H1 MARGINS WERE MAINTAINED ON LOWER VOLUMES DUE TO WEAKNESS IN Q2.MEDICLINIC INTERNATIONAL PLC - FOR FULL YEAR, PERFORMANCE IN SOUTHERN AFRICA REMAINS IN LINE WITH GUIDANCE.MEDICLINIC INTERNATIONAL PLC - IN MIDDLE EAST, FULL YEAR EBITDA DELIVERY REMAINS ON TRACK WITH REVENUE GROWTH LOWER THAN PREVIOUSLY EXPECTED.MEDICLINIC INTERNATIONAL PLC - IN SWITZERLAND, WE NOW EXPECT TO DELIVER MODEST REVENUE GROWTH IN FULL YEAR.MEDICLINIC INTERNATIONAL PLC - AT GROUP LEVEL, IN CONSTANT CURRENCY, 1H19 REVENUE WAS UP 2% AND ADJUSTED EBITDA WAS DOWN AROUND 4%.  Full Article

Mediclinic International Says Guidance Remains Unchanged With Trading In Line With Expectations
Thursday, 28 Jun 2018 

June 28 (Reuters) - Mediclinic International PLC ::GUIDANCE REMAINS UNCHANGED WITH TRADING IN LINE WITH EXPECTATIONS.  Full Article

Mediclinic International Says CEO To Continue As A Non-Executive Director
Thursday, 24 May 2018 

May 24 (Reuters) - Mediclinic International PLC ::CHIEF EXECUTIVE OFFICER TO CONTINUE AS A NON-EXECUTIVE DIRECTOR.CHIEF EXECUTIVE OFFICER TO CONTINUE AS A NON-EXECUTIVE DIRECTOR.RONNIE VAN DER MERWE WILL SUCCEED MEINTJES AS CHIEF EXECUTIVE DIRECTOR ON 1 JUNE 2018.  Full Article

Mediclinic International appoints Carel Aron Van Der Merwe as CEO designate​
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Mediclinic International Plc ::‍ANNOUNCES APPOINTMENT OF CAREL ARON VAN DER MERWE, CURRENTLY GROUP CHIEF CLINICAL OFFICER, AS CHIEF EXECUTIVE OFFICER DESIGNATE​.MERWE ‍TO SUCCEED DANIE MEINTJES AS CEO OF COMPANY ON A DATE TO BE MUTUALLY AGREED, BUT NOT LATER THAN 1 AUGUST 2018​.  Full Article

Mediclinic International says H1 2018 ‍underlying EPS down 12 pct to 11.3 pence​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - MEDICLINIC INTERNATIONAL PLC ::H1 2018 ‍UNDERLYING EARNINGS PER SHARE DOWN 12% TO 11.3 PENCE​.‍H1 REVENUE UP 10% TO GBP1 405M; FLAT IN CONSTANT CURRENCY TERMS​.‍H1 UNDERLYING EBITDA UP 5% TO GBP232M; DECREASED BY 5% IN CONSTANT CURRENCY TERMS​.‍INTERIM DIVIDEND MAINTAINED AT 3.20 PENCE PER SHARE​.SEES MODEST REVENUE GROWTH IN ‍HIRSLANDEN FOR H2​.‍FOR SOUTHERN AFRICA GROUP EXPECTS REVENUE GROWTH TO BE AROUND 4%​ IN H2.‍SEES MARGINAL IMPROVEMENT IN MIDDLE EAST REVENUES FOR FULL YEAR, GRADUAL IMPROVEMENT IN UNDERLYING EBITDA MARGINS OVER TIME,​.‍HAD A GOOD START TO SECOND HALF OF FINANCIAL YEAR, WITH CURRENT TRADING ACROSS ALL OPERATING DIVISIONS IN LINE WITH EXPECTATIONS​.‍GUIDANCE FOR ALL OPERATING DIVISIONS REMAINS UNCHANGED WITH CURRENT 2H18 TRADING IN LINE WITH MANAGEMENT​.  Full Article

Mediclinic confirms approach to Spire; says considering position
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Mediclinic International Plc ::MEDICLINIC INTNL PLC - STATEMENT RE POSSIBLE OFFER.MEDICLINIC INTERNATIONAL PLC - ‍ANNOUNCEMENT REGARDING SPIRE HEALTHCARE GROUP PLC​.‍MEDICLINIC NOTES ANNOUNCEMENT MADE BY SPIRE HEALTHCARE GROUP PLC ("SPIRE") EARLIER TODAY​.MEDICLINIC - ‍CONFIRMS THAT IT MADE AN APPROACH TO SPIRE REGARDING A POSSIBLE OFFER FOR ENTIRE ISSUED AND TO BE ISSUED SHARE CAPITAL OF SPIRE​.‍PROPOSAL WAS REJECTED BY INDEPENDENT DIRECTORS OF SPIRE. AS A CONSEQUENCE, MEDICLINIC IS CONSIDERING ITS POSITION​.  Full Article

UK's Spire says rejects bid from Mediclinic Intl
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Spire Healthcare Group Plc ::SPIRE HEALTHCARE GRP - RESPONSE TO PRESS SPECULATION.SPIRE HEALTHCARE - ‍RECEIVED PRELIMINARY AND CONDITIONAL PROPOSAL FROM MEDICLINIC INTERNATIONAL PLC.SPIRE HEALTHCARE - ‍RECEIVED PROPOSAL TO ACQUIRE ALL OF ISSUED AND TO BE ISSUED SHARES OF SPIRE WHICH MEDICLINIC DOES NOT ALREADY OWN​.‍PROPOSAL COMPRISED 150 PENCE IN CASH AND 0.232 NEW MEDICLINIC SHARES PER SPIRE SHARE​.‍PROPOSAL VALUED EACH SPIRE SHARE AT 298.6 PENCE PER SHARE​.BOARD ‍UNANIMOUSLY REJECTED OFFER ON BASIS THAT IT SIGNIFICANTLY UNDERVALUES SPIRE AND ITS PROSPECTS​.‍SHAREHOLDERS ARE STRONGLY ADVISED TO TAKE NO ACTION IN RELATION TO PROPOSAL​.‍THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE OR AS TO TERMS ON WHICH ANY OFFER MIGHT BE MADE​.  Full Article

Ex-divs to take 1 point off FTSE 100 on Dec 13

LONDON, Dec 10 The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by market-makers would take 1 point off the index. COMPANY (RIC) DIVIDEND STOCK OPTION IMPACT (pence) Asso